Evaluation of the treatment with gonadotropic hormones in cases of severe and moderate oligozoospermia.
Here are reported results of a study based on the administration during 13 weeks of Pergonal-Profasi, in cases of oligozoospermia. When comparing these data to others obtained previously, conclusion can be drawn that administration of these gonadotropic hormones is mainly indicated to patients showing, on the one hand, oligozoospermia combined, on the other hand, with subnormal FSH-values. Though no investigation was made on this point, it can be expressed that specifically in cases of patients with very low FSH levels a treatment consisting of prolonged administration with higher dosages has to be preferred.
D004341:Drug Evaluation; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008596:Menotropins / Q000627:therapeutic use*; D009845:Oligospermia / Q000188:drug therapy*
D008596:Menotropins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone